Board Meeting5 Nov 2026, 05:34 pm
Goldline Pharmaceutical Ltd Board Meeting on Nov 14, 2026
AI Summary
Goldline Pharmaceutical Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda item is to consider and approve the standalone unaudited financial results for the half-year ended September 30, 2026, along with the Statement of Assets and Liabilities. The outcome of this meeting will be communicated separately.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- To approve standalone unaudited financial results.
- Financial results for the half-year ended September 30, 2026.
- Statement of Assets and Liabilities to be reviewed.
Price Impact
More from GLPL